Work

TACE plus sorafenib for the treatment of hepatocellular carcinoma: results of the multicenter, phase II SOCRATES trial

Year: 2014

Type: article

Study design: Clinical Trial

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-014-2568-8

Authors: Andreas Erhardt, Frank Kolligs, Matthias Dollinger, Eckart Schott, Hennig Wege, Michael Bitzer, Christiane Gog, Frank Lammert, Markus Schuchmann, Clemens Walter, Dirk Blondin, Christian Ohmann, Dieter Häussinger

Institutions: Heinrich Heine University Düsseldorf, Ludwig-Maximilians-Universität München, Martin Luther University Halle-Wittenberg, Charité – Universitätsmedizin Berlin, University Medical Center Hamburg-Eppendorf, University of Tübingen, Goethe University Frankfurt, Universitätsklinikum des Saarlandes, Johannes Gutenberg University Mainz

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Bayer, Bayer HealthCare, European Association for the Study of the Liver

OpenAlex ID: W2011663359

FWCI: 6.199

Cites: 33

Cited by: 70

Related to: 10